Catheryn D. Wilson
Researcher
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Catheryn D. Wilson studies the effects of synthetic cannabinoid receptor agonists in mice, focusing on tolerance, dependence, and withdrawal. Her research investigates the potential for convulsive effects from these substances, examining whether specific synthetic cannabinoids elicit electroencephalographic (EEG) seizures in male mice. Wilson's work contributes to understanding the pharmacological profiles and potential toxicities of abused synthetic cannabinoids. She has published 11 papers with 220 citations and an h-index of 7. Her key collaborators include William E. Fantegrossi and Fang Zheng, both from the University of Arkansas for Medical Sciences, with whom she has co-authored multiple publications.
Metrics
- h-index: 7
- Publications: 11
- Citations: 221
Selected Publications
-
Convulsant doses of abused synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA and JWH-018 do not elicit electroencephalographic (EEG) seizures in male mice (2022)
-
Cannabimimetic effects of abused indazole-carboxamide synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA and 5F-ADB-PINACA in mice: Tolerance, dependence and withdrawal (2022)
-
In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome (2019)
-
<i>In vitro</i> and <i>In vivo</i> Effects of Phase 1 Hydroxylated Metabolites of the Synthetic Cannabinoid AB‐PINACA [(S)‐N‐(1‐amino‐3‐methyl‐1‐oxobutan‐2‐yl)‐1‐pentyl‐1H‐indazole‐3‐carboxamide] (2018)
-
2421 Development and validation of a translational rat model of neonatal abstinence syndrome (2018)
-
Convulsant Effects of Abused Synthetic Cannabinoids JWH-018 and 5F-AB-PINACA Are Mediated by Agonist Actions at CB1 Receptors in Mice (2018)
-
Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ9-THC (2018)
-
Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist / CB2R agonist aminoalkylindole derivatives in mice (2018)
-
Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems (2018)
-
The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces analgesia in mice (2017)
-
Characterization of structurally novel G protein biased CB 1 agonists: Implications for drug development (2017)
Collaboration Network
Top Collaborators
- Cannabimimetic effects of abused indazole-carboxamide synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA and 5F-ADB-PINACA in mice: Tolerance, dependence and withdrawal
- Convulsant doses of abused synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA and JWH-018 do not elicit electroencephalographic (EEG) seizures in male mice
- Cannabimimetic effects of abused indazole-carboxamide synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA and 5F-ADB-PINACA in mice: Tolerance, dependence and withdrawal
- Convulsant doses of abused synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA and JWH-018 do not elicit electroencephalographic (EEG) seizures in male mice
Similar Researchers
Based on overlapping research topics